JPWO2022010880A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022010880A5 JPWO2022010880A5 JP2023500279A JP2023500279A JPWO2022010880A5 JP WO2022010880 A5 JPWO2022010880 A5 JP WO2022010880A5 JP 2023500279 A JP2023500279 A JP 2023500279A JP 2023500279 A JP2023500279 A JP 2023500279A JP WO2022010880 A5 JPWO2022010880 A5 JP WO2022010880A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- alkoxy
- cycloalkyl
- group
- epilepsy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063048335P | 2020-07-06 | 2020-07-06 | |
| US63/048,335 | 2020-07-06 | ||
| PCT/US2021/040486 WO2022010880A1 (en) | 2020-07-06 | 2021-07-06 | Kcnt1 inhibitors and methods of use |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023532985A JP2023532985A (ja) | 2023-08-01 |
| JPWO2022010880A5 true JPWO2022010880A5 (https=) | 2024-07-11 |
| JP2023532985A5 JP2023532985A5 (https=) | 2024-07-11 |
| JP7824664B2 JP7824664B2 (ja) | 2026-03-05 |
Family
ID=79552679
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023500279A Active JP7824664B2 (ja) | 2020-07-06 | 2021-07-06 | Ｋｃｎｔ１阻害剤及び使用方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230219921A1 (https=) |
| EP (1) | EP4175624A4 (https=) |
| JP (1) | JP7824664B2 (https=) |
| KR (1) | KR20230035608A (https=) |
| CN (1) | CN116075297A (https=) |
| AU (1) | AU2021305058A1 (https=) |
| CA (1) | CA3188825A1 (https=) |
| IL (1) | IL299700B1 (https=) |
| MX (1) | MX2023000360A (https=) |
| WO (1) | WO2022010880A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20250172745A (ko) * | 2019-05-03 | 2025-12-09 | 프락시스 프리시젼 메디신즈, 인크. | Kcnt1 억제제 및 사용 방법 |
| KR20220016086A (ko) * | 2019-05-03 | 2022-02-08 | 프락시스 프리시젼 메디신즈, 인크. | Kcnt1 억제제 및 사용 방법 |
| JP7699836B2 (ja) | 2020-02-28 | 2025-06-30 | プラクシス プレシジョン メディシンズ， インコーポレイテッド | Ｋｃｎｔ１阻害剤、および使用方法 |
| US11773088B2 (en) | 2020-11-02 | 2023-10-03 | Praxis Precision Medicines, Inc. | KCNT1 inhibitors and methods of use |
| IL316283A (en) * | 2022-04-25 | 2024-12-01 | Praxis Prec Medicines Inc | KCNT1 inhibitors comprising a pyrazole core and methods of use |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0127547D0 (en) * | 2001-11-16 | 2002-01-09 | Astrazeneca Ab | Chemical compounds |
| US20050026968A1 (en) * | 2003-07-14 | 2005-02-03 | University Of Tennessee Research Foundation | Heterocyclic amides with anti-tuberculosis activity |
| US20080269241A1 (en) * | 2007-02-15 | 2008-10-30 | Darin Allen | Bicyclic aminopropyl tetrahydro-pyrazolo-pyridine modulators of cathepsin s |
| RS54303B1 (sr) * | 2007-07-19 | 2016-02-29 | Lundbeck, H., A/S | 5-člani heterociklični amidi i srodna jedinjenja |
| WO2019018119A1 (en) * | 2017-07-18 | 2019-01-24 | Pairnomix, Llc | METHODS FOR TREATING EPILEPSY AND DISORDERS ASSOCIATED WITH KCNTI |
| JP2022529663A (ja) * | 2019-04-26 | 2022-06-23 | ハー・ルンドベック・アクチエゼルスカベット | Ｋｖ３カリウムチャネル活性化薬としてのアリールスルホニルチオフェンカルボキサミド及びアリールスルホニルフランカルボキサミド |
| KR20250172745A (ko) * | 2019-05-03 | 2025-12-09 | 프락시스 프리시젼 메디신즈, 인크. | Kcnt1 억제제 및 사용 방법 |
-
2021
- 2021-07-06 CA CA3188825A patent/CA3188825A1/en active Pending
- 2021-07-06 KR KR1020237004094A patent/KR20230035608A/ko active Pending
- 2021-07-06 IL IL299700A patent/IL299700B1/en unknown
- 2021-07-06 CN CN202180053935.4A patent/CN116075297A/zh active Pending
- 2021-07-06 EP EP21838577.1A patent/EP4175624A4/en active Pending
- 2021-07-06 MX MX2023000360A patent/MX2023000360A/es unknown
- 2021-07-06 AU AU2021305058A patent/AU2021305058A1/en active Pending
- 2021-07-06 JP JP2023500279A patent/JP7824664B2/ja active Active
- 2021-07-06 WO PCT/US2021/040486 patent/WO2022010880A1/en not_active Ceased
- 2021-07-06 US US18/004,417 patent/US20230219921A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102717594B1 (ko) | 혈액 장애의 치료에 사용하기 위한 피루브산 키나아제 활성화제 | |
| JP6964576B2 (ja) | 置換４−アザインドール及びｇｌｕｎ２ｂ受容体調節因子としてのそれらの使用 | |
| CN109810041B (zh) | 卤代烯丙基胺类ssao/vap-1抑制剂及其应用 | |
| RU2196139C2 (ru) | 1,4,5-тризамещенные производные имидазола, способы их получения и фармацевтическая композиция на их основе | |
| JP6281984B2 (ja) | １，２，４−トリアジン−６−カルボキサミドキナーゼ阻害剤 | |
| TW202200552A (zh) | 作為用於免疫活化之DGKζ抑制劑之經取代胺基噻唑 | |
| CA2947002C (en) | Pyrazole compounds and their use as t-type calcium channel blockers | |
| JP2004536104A5 (https=) | ||
| JP2019530695A (ja) | 置換１Ｈ−イミダゾ［４，５−ｂ］ピリジン−２（３Ｈ）−オン及びＧＬＵＮ２Ｂ受容体調節因子としてのそれらの使用 | |
| JP2005514398A5 (https=) | ||
| JP2004509113A5 (https=) | ||
| RU2004116916A (ru) | Производные 5,6-биарил-пиразин-2-амида в качестве антагонистов cb1 | |
| WO2004106293A2 (en) | Oxazolyl - and thiazolyl - purine based tricyclic compounds. | |
| JP2011510004A (ja) | タンパク質キナーゼ阻害剤及びその使用 | |
| JP2022536424A (ja) | 置換ヘテロ芳香族ピラゾロピリジン及びｇｌｕｎ２ｂ受容体調節因子としてのそれらの使用 | |
| JP2025534288A (ja) | １，４－ジヒドロキナゾリノン化合物およびその使用 | |
| JPWO2022010880A5 (https=) | ||
| KR900008318B1 (ko) | 치료제로서 유용한 4-아릴-5-카바모일-1, 4-디하이드로피리딘 | |
| CN106795152B (zh) | 蛋白激酶抑制剂 | |
| JPWO2020227097A5 (https=) | ||
| CN101304981A (zh) | P2x7受体拮抗剂及使用方法 | |
| CN107531634A (zh) | 作为wnt信号通路抑制剂的3‑氨基甲酰基苯基‑4‑甲酰胺和间苯二甲酰胺衍生物 | |
| US20110201648A1 (en) | Poly-heteroaryl derivatives for the treatment of cancer | |
| JP2024534571A (ja) | ナトリウムチャネル活性化剤としてのピリジン誘導体及びその使用 | |
| CA3209830A1 (en) | Tyk2 inhibitor compound containing bicyclic ring |